Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Arcadia Biosciences, Inc. (RKDA) had Weighted-Average Shares Outstanding (Diluted) of 1.37M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.30M |
|
$0.86M |
|
$0.88M |
|
$0.42M |
|
$2.45M |
|
$-1.15M |
|
$2.01M |
|
$0.86M |
|
$0.86M |
|
$0.86M |
|
$0.86M |
|
$0.86M |
|
$0.86M |
|
$-1.15M |
|
$-1.15M |
|
1.37M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.37M |
$0.63 |
|
$0.62 |
|
| Balance Sheet Financials | |
$8.39M |
|
$0.01M |
|
$0.20M |
|
$8.58M |
|
$2.29M |
|
-- |
|
$0.86M |
|
$3.14M |
|
$5.44M |
|
$5.40M |
|
$5.44M |
|
1.37M |
|
| Cash Flow Statement Financials | |
$-3.88M |
|
$0.75M |
|
$0.01M |
|
$4.24M |
|
$1.12M |
|
$-3.12M |
|
$0.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
32.10% |
|
-88.48% |
|
-88.48% |
|
-- |
|
65.75% |
|
65.75% |
|
$-3.88M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.61 |
|
1.57 |
|
57.44 |
|
15.73% |
|
15.84% |
|
9.97% |
|
15.73% |
|
$3.98 |
|
$-2.83 |
|
$-2.83 |
|